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Resumo
Os profissionais de saúde (PS) têm um risco aumen-
tado de tuberculose. O rastreio da tuberculose latente 
e da tuberculose activa é portanto essencial nos pro-
gramas de controlo de infecção. Entre Maio de 2007 
e Abril de 2009, foram utilizados simultaneamente a 
prova de tuberculina (PT) e o teste de libertação do 
interferão -γ (IGRA) em 1686 PS. Quando PT 
≥10mm ou IGRA positivo, e em PS com contacto 
com tuberculose ou sintomáticos, foi realizada uma 
radiografia torácica para excluir tuberculose activa. O 
IGRA foi positivo em 33,1% e a PT foi >10mm em 
Abstract
Healthcare workers (HCWs) have an increased risk 
of tuberculosis (TB). Screening for latent tuberculo-
sis infection and active TB is therefore essential in 
infection control programs. Tuberculin skin test 
(TST) and Interferon -γ Release Assay (IGRA) were 
used simultaneously in 1686 HCWs between May 
2007 and April 2009. A chest X -ray was performed 
in order to exclude active TB when TST was ≥10mm 
or IGRA was positive and in HCWs with TB contact 
or symptoms. IGRA was positive in 33.1% and TST 
was >10mm in 78.3% of the HCWs. The proportion 
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78.3% dos PS. A proporção de resultados IGRA po-
sitivos aumentou com o diâmetro da PT. Nos PS com 
PT >15mm, 49.2% são IGRA positivos. A PT foi 
positiva em mais do dobro dos casos do IGRA. As-
sim, foram observados mais frequentemente resulta-
dos PT+/IGRA- do que resultados concordantes ne-
gativos ou positivos. Em nenhum PS com resultado 
PT+/IGRA- foi diagnosticada tuberculose activa du-
rante o período do estudo. A vacinação repetida pelo 
BCG aumentou o número de casos discordantes 
PT+/IGRA -. Quanto menor o intervalo após a vaci-
nação pelo BCG, maior a discordância PT+/IGRA -.
Na população de PS rastreada, foram diagnosticados 
9 casos de tuberculose activa, sendo todos PT e IGRA 
positivos na altura do diagnóstico. Este estudo durou 
24 meses, pelo que a taxa de incidência anual média 
foi de 268/100 000.
A tuberculose é um problema importante nos PS em 
Portugal. Considerando as limitações que a PT e 
IGRA apresentam, a melhor solução parece ser o uso 
de ambos, utilizando a maior especificidade do IGRA 
para confirmar uma PT positiva, aproveitando as me-
lhores características de cada teste.
Rev Port Pneumol 2010; XVI (2): 211-221
Palavras -chave: Tuberculose, profissionais de saúde, 
prova de tuberculina, teste de libertação do interferão-
-γ, Portugal.
of positive IGRA results increased with the TST dia-
meter. In those with a TST >15mm, 49.2% were 
IGRA positive. TST was more than twice as often 
positive than the IGRA. Therefore, TST+/IGRA- re-
sults were more often observed than concordant ne-
gative or positive results. In none of the HCWs with 
a TST+/IGRA- result active TB was diagnosed dur-
ing the study period. Repeated BCG vaccination in-
creased the number of TST+/IGRA- discordance. 
The smaller the interval after BCG vaccination, the 
higher was the TST+/IGRA- discordance.
In the screened HCWs population, active TB was dia-
gnosed in 9. At the time of diagnosis TST and IGRA 
were positive in all active TB cases. The study period 
covers 24 months, therefore the average annual inci-
dence rate was 268/100 000.
TB burden in HCWs in Portugal is high. Consider-
ing the limitations that TST and IGRA present, the 
best solution seems to be the use of both, using the 
IGRA higher specificity for confirming a positive 
TST, taking advantage of the best characteristics of 
each test.
Rev Port Pneumol 2010; XVI (2): 211-221
Key -words: Tuberculosis, healthcare workers, tuber-
culin skin test, interferon -γ release assay, Portugal.
Introduction
The increased risk of healthcare workers 
(HCWs) for tuberculosis is well established1 -3. 
Screening HCWs for latent tuberculosis in-
fection (LTBI) and active tuberculosis (TB) 
is therefore fundamental in infection control 
programs in hospitals4. For about a century, 
the tuberculin skin test (TST) has been used 
to detect LTBI. The TST measures the hy-
persensitive response to purified protein de-
rivative (PPD), a crude mixture of antigens, 
many of which are shared by M. tuberculosis, 
M. bovis (source of the Calmette -Guérin ba-
cillus; BCG), and several non -tubercular 
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mycobacteria (NTM). Although the TST 
has proved to be useful in clinical practice, it 
has known limitations, including cross-
reactivity with BCG and NTM infections5.
Advances in molecular biology have led to 
the development of a new in vitro assay that 
measures interferon (INF) -γ released by sen-
sitized T cells after stimulation with M. tu-
berculosis antigens. These antigens include 
early secreted antigenic target (ESAT) -6 and 
culture filtrate protein (CFP) -10. ESAT -6 
and CFP -10 are encoded by genes located 
within the region of difference (RD) -1 seg-
ment of the M. tuberculosis genome. Two 
new T -cell -based tests for diagnosing LTBI 
have been developed and licensed for com-
mercial distribution: QuantiFERON (QFT)-
TB Gold in Tube® (Cellestis, Victoria, Aus-
tralia) uses an enzyme -linked immunosorbent 
assay (ELISA) to measure antigen -specific 
production of INF -γ by circulating T cells in 
whole blood; T -SPOT.TB® (Oxford Immu-
notec, Oxford, United Kingdom) uses the 
Elispot technique to measure peripheral 
blood mononuclear cells that produce INF 
-γ. These tests are more specific than the TST 
using PPD, because they use antigens not 
shared by any of the BCG vaccine strains nor 
by the more common species of NTM (e.g. 
M. avium)6. Research on test performance 
has shown that assays using RD1 antigens are 
more specific than TST, have a better correla-
tion with surrogate measures of exposure to 
M. tuberculosis in low incidence settings, and 
exhibit less cross -reactivity due to BCG vac-
cination than the TST7,8. In the absence of a 
gold standard for LTBI, active TB is used as a 
surrogate for LTBI to judge sensitivity. In a 
meta -analysis, the pooled sensitivity and 
specificity for the IGRA were higher than for 
TST9. The IGRA has potential advantages 
besides its greater specificity, including logis-
tical convenience (no second patient contact 
for reading the test), easier interpretation of 
the test results (cut -off point is independent 
from the risk status of the patient) and the 
ability to perform serial testing without in-
ducing the boosting phenomenon. A recent 
study demonstrated that the IGRA has me-
rits in screening close contacts for LTBI in 
low incidence areas10. Within the first two 
years after contact, the progression rate to ac-
tive TB for IGRA -positive was three times 
higher than with TST positive contacts.
So far only few systematic investigations of 
LTBI in HCWs using the IGRA have been 
published11 -17. Therefore, we screened for 
LTBI in Portuguese HCWs using IGRA 
and TST and compared the performance of 
boht tests.
Materials and methods
Study setting and study subjects
In compliance with EU regulations, the 
Hospital S. João, Porto – Portugal, imple-
mented an Occupational Health Division 
for the hospital staff. Since May 2007 the 
workers of this hospital have been offered 
TB screening with TST and IGRA simulta-
neously by this Division. Screening follows 
the Centers for Disease Control and Pre-
vention (CDC) guidelines4. Upon com-
mencement of employment, all workers are 
examined to exclude active TB and to assess 
their pre -employment status. Depending 
on risk assessment, the examination is re-
peated annually or every other year. HCWs 
with close patient contact in the infection 
and TB wards are considered at high risk, 
workers with regular patient contact in the 
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other wards are considered at medium risk 
and workers with no regular patient contact 
or no contact with biological material are 
considered at low risk. Screening is per-
formed annually for those with contact with 
TB patients or infectious material. For all 
other HCWs screening is scheduled bi-
annually. After unprotected contact with an 
infectious patient or material, an additional 
screening is performed as well.
The data presented here comprise all HCWs 
screened between May 2007 and April 2009 
using TST and IGRA simultaneously. TST 
was only performed when the diameter of a 
previous TST was below 15 mm or when no 
previous TST result was known. A chest 
X -ray was performed in order to exclude ac-
tive pulmonary disease when TST was 10 
mm or higher or IGRA was positive and in 
HCWs with TB contact or symptoms.
BCG vaccination was assessed through the 
individual vaccination register. If no register 
was available, vaccination status was verified 
by scars. According to the Portuguese Natio-
nal Vaccination Plan18, BCG vaccination is 
administered in newborns, and until January 
2000 was repeated if TST diameter was below 
5 mm. Therefore, every HCW was consi-
dered to have been vaccinated at least once.
Tuberculin skin test
TST was performed by trained personnel 
following standard procedures. Briefly, 0.1 
mL (2 TU) of purified protein derivate 
(PPD, RT23; Statens Serum Institute, Co-
penhagen, Denmark) were injected in the 
volar side of the forearm of the participants 
and read 72 to 96 hours afterwards. The 
transverse diameter of the induration was 
measured by experienced personnel.
Before the TST application, the interview 
was performed and blood for the IGRA was 
drawn. For the IGRA, the QuantiFERON-
-TB® Gold In -Tube Assay (Cellestis Limited, 
Carnegie, Australia) was used. This whole 
blood assay uses overlapping peptides corres-
ponding to ESAT -6, CFP -10, and a portion 
of tuberculosis antigen TB7.7 (Rv2654). 
Stimulation of the antigenic mixture occurs 
within the tube used to collect blood. Tubes 
were incubated at 37oC overnight before 
centrifugation, and INF -γ release was mea-
sured by ELISA following the protocol of 
the manufacturer. All assays performed met 
the manufacturer’s quality control standards. 
The test was considered positive when INF -γ 
was ≥ 0.35 IU after correction for the nega-
tive control. Observers were blinded to the 
results of the TST results.
Statistical analysis
Chi -square test was used to compare fre-
quencies of test results among different 
groups of participants. For ordered risks, 
the proportions of positive test results were 
compared using the chi -square test of trend. 
The agreement between TST and QFT in-
dependent from the agreement by chance 
alone was assessed by calculating Kappa va-
lues for TST >10 mm and TST >15 mm. P 
<0.05 was considered statistically signifi-
cant. Adjusted odds ratios (OR) and 95% 
confidence intervals (CI) were calculated 
for different putative predictive variables us-
ing conditional logistic regression. Model 
building was performed backwards using 
the chance criteria for variable selection19.
Data analysis was performed with SPSS, 
Version 14 (SPSS Inc., Chicago, Illinois). 
All people gave their informed consent prior 
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to their inclusion in the study. No additio-
nal data were collected for the study pur-
pose only and analysis was performed with 
anonymous data. Therefore, no endorse-
ment by an ethics committee was required.
Results
TST and QFT were performed in 1686 
HCWs. The population available for analy-
sis comprises 1682 HCWs since QFT was 
undetermined in 4 (0.2%). Their characte-
ristics are described in Table I. The TST was 
>10 mm in 78.3% and the QFT was posi-
tive in 33.1%. The proportion of positive 
QFT results increase with the diameter of 
the TST (Table II). In those with a TST >15 
mm, 49.2% are positive in the QFT. Agree-
ment between TST and QFT was higher 
with >15 mm instead of >10 mm as cut off 
for TST (0.18 versus 0.29). For both cut 
offs agreement decreased with number of 
BCG vaccination (Table III), but even in 
those vaccinated at birth only, Kappa was 
low for both the >10 mm (0.26) and for the 
>15 mm (0.37) cut off for TST. Moving the 
cut off for TST from >10 to >15 mm did 
not yield good agreement between QFT 
and TST (Table III) and as a drawback in-
creased the number of TST -/QFT+ discor-
dant results from 33 (2%) to 202 (12%) as 
can be calculated from Table II. Therefore, 
further analysis were undertaken with TST 
>10 mm as cut off.
With age the proportion of positive TST or 
QFT increased (Table IV). In those 60 years 
or older the proportion of positive TST de-
clined compared to those 40 -40 years or 50 -
59 years old while for the QFT a linear asso-
ciation was seen over all age groups. Repeated 
BCG vaccination was not associated with the 
probability of a positive TST but decreased 
the proportion of positive QFT. When a BCG 
vaccination was performed during the last 10 
years, the odds ratio for a positive TST was 
increased with a borderline statistically signifi-
cant confidence interval (OR 1.5; 95%CI 
Table I – Study population for comparison of IGRA with TST 
(n=1682)
Age N %
 16 -29 years 601 35.7
 30 -39 years 463 27.5
 40 -49 years 313 18.6
 50 -59 years 271 16.1
 ≥ 60 years 34 2.0
Gender
 Female 1211 72.0
 Male 471 28.0
BCG vaccination
 Only at birth 498 29.6
 One additional 631 37.5
 Two additional 396 23.5
 3 -10 additional 157 9.3
Years since last BCG
 > 15 years 1247 74.1
 > 10 -15 years 277 16.5
 1 -10 years 158 9.4
Profession
 Administrative 251 14.9
 Auxiliaries, cleaning staff 254 15.1
 Technicians 119 7.1
 Nurses 720 42.8
 Physicians 338 20.1
Risk assessment
 Low risk 223 13.3
 Moderate risk 626 37.2
 High risk 833 49.5
Years working in healthcare
 Start of work 349 20.7
 < 5 years 396 23.5
 5 ≤ 10 years 263 15.6
 10 ≤ 15 years 210 12.5
 15 -< 20 years 133 7.9
 ≥ 20 years 331 19.7
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1.0 -2.4) and the odds ratio for a positive QFT 
was well below 1 (OR 0.4; 95%Ci 0.3 -0.7). 
Profession was not associated with the TST, 
while doctors had a slightly increased odds ra-
tio for a positive QFT (OR 1.4; 95%CI 1.0-
2.0), again with a borderline statistically sig-
nificant confidence interval. Risk assessment, 
according to the CDC guidelines4, was nei-
ther associated with TST nor with QFT while 
a positive association was found between years 
in healthcare and the TST as well as the QFT. 
Due to colliniarity problems age and years 
working in healthcare could not be introduced 
in the same model. Therefore, the effect of 
these two variables on TST or QFT could not 
be distinguished.
Most often TST+/QFT– results (47.1%) fol-
lowed by concordant positive results (31.2%) 
occurred (Table V). With age the number of 
concordant positive results increased while the 
proportion of TST+/QFT– discordant results 
decreased. Repeated BCG vaccination in-
creased the number of TST+/QFT– discor-
dance. The smaller the interval after BCG vac-
cination the higher was the proportion of 
TST+/QFT– discordance. Nurses had less of-
ten positive concordant results than adminis-
tratives, auxiliaries and physicians. At the same 
time, they had the highest rate of TST+/QFT– 
discordance. Surprisingly, the higher the as-
sumed risk of infection the lower was the pro-
portion of TST+/QFT+ concordance. Years 
working in healthcare increased the probabi-
lity of TST+/QFT+ concordance but were not 
associated with TST+/QFT– discordance.
In these 1682 HCWs for whom TST and 
QFT results are available, active TB was 
dia gnosed in 9 HCWs. Diagnosis was based 
on culture confirmed positive smear in 7 
cases, on culture in 1 and on PCR also in 1. 
At the time of diagnosis TST and QFT were 
positive in all active TB cases. The study pe-
riod covers 24 month, therefore the average 
annual incidence rate was 268/100 000.
Table II – TST diameter by IGRA results
IGRA
TST Negative Positive Total
N Row% N Row% N Col%
0 -5 mm 177 94.7 10 5.3 187 11.1
6 -10 mm 155 87.1 23 12.9 178 10.6
11 -15 mm 423 71.6 168 28.4 591 35.1
> 15 mm 369 50.8 357 49.2 726 43.2
All 1124 66.8 558 33.2 1682 100.0
TST = Tuberculin skin test
IGRA = Interferon -γ -release assay
Row% = Row -percent
Col% = Column -percent
Table III – Agreement assessed by Kappa between TST 
and QFT depending on number of BCG vaccinations and 
cut off for TST
TST
> 10mm > 15mm
BCG Kappa (p) Kappa (p)
 at birth 0.25 (0.001) 0.37 (0.001)
 1 add 0.16 (0.001) 0.24 (0.001)
 2 add 0.11 (0.001) 0.19 (0.001)
 3 -10 add 0.11 (0.004) 0.17 (0.001)
All 0.18 (0.001) 0.29 (0.001)
p = p value
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Discussion
The study presented here is one of the lar-
gest European studies analyzing risk factors 
for LTBI by using QFT and TST simulta-
neously. It is also the only cross -sectional 
study that observed active TB in HCWs in 
a cross -sectional design. The agreement be-
tween TST and QFT was low and could not 
be improved by increasing the cut off for 
the TST from >10 to >15 mm because this 
Table IV – Proportion of tuberculin skin test (TST) >10 mm and positive interferon -γ -release assay (IGRA) and the respec-
tive adjusted odds ratios (OR) and 95% confi dence intervals (CI) for different putative risk factors
TST > 10mm IGRA -positive
Age N (%) OR 95%CI N (%) OR 95% CI
16 -29 years 425 (70.7) 1  - - 133 (22.1) 1  - -
30 -39 years 356 (76.9) 1.3 1.0 -1.7 150 (32.4) 1.6 1.2 -2.1
40 -49 years 271 (86.6) 2.5 1.7 -3.6 127 (40.6) 1.8 1.3 -2.5
50 -59 years 238 (87.8) 2.6 1.7 -4.0 129 (47.6) 2.0 1.4 -2.9
≥ 60 years 27 (79.4) 1.3 0.6 -3.0 19 (55.9) 2.6 1.3 -5.4
Gender
Female 951 (78.5) 1  - - 390 (32.2) 1  - -
Male 366 (77.7) 0.9 0.7 -1.2 168 (35.7) 1 0.8 -1.2
BCG vaccination
Only at birth 417 (83.7) 1  - - 234 (47.0) 1  - -
One additional 487 (77.2) 0.8 0.6 -1.1 199 (31.5) 0.7 0.5 -0.9
Two additional 296 (74.7) 0.8 0.6 -1.2 98 (24.7) 0.7 0.5 -0.9
3 -10 additional 117 (74.5) 0.9 0.5 -1.4 27 (17.2) 0.5 0.3 -0.8
Years since last BCG
> 15 years 996 (79.9) 1  - - 479 (38.4) 1  - -
> 10 -15 years 188 (67.9) 0.7 0.5 -0.9 53 (19.1) 0.6 0.4 -0.9
1 -10 years 133 (84.2) 1.5 1.0 -2.4 26 (16.5) 0.4 0.3 -0.7
Profession
Administrative 212 (84.5) 1  - - 104 (41.4) 1  - -
Auxiliaries, cleaning staff 197 (77.6) 0.8 0.5 -1.3 99 (39.0) 1.0 0.7 -1.5
Technicians 94 (79.0) 1.0 0.6 -1.8 34 (28.6) 0.8 0.5 -1.3
Nurses 559 (77.6) 1.2 0.8 -1.9 182 (25.3) 0.7 0.5 -1.0
Physicians 255 (75.4) 1.0 0.6 -1.5 139 (41.1) 1.4 1.0 -2.0
Risk assessment
Low risk 192 (86.1) 1  - - 98 (43.9) 1  - -
Moderate risk 497 (79.4) 0.9 0.5 -1.3 204 (32.6) 0.7 0.5 -1.1
High risk 628 (75.4) 0.6 0.4 -1.0 256 (30.7) 0.7 0.5 -1.0
Years working in healthcare
Start of work 243 (69.6) 1  - - 93 (26.6) 1  - -
< 5 years 289 (73.0) 1.3 0.9 -1.8 97 (24.5) 1.1 0.8 -1.6
5 ≤ 10 years 198 (75.3) 1.3 0.9 -1.9 84 (31.9) 1.7 1.1 -2.5
10 ≤ 15 years 179 (85.2) 2.5 1.6 -4.0 76 (36.2) 2.0 1.3 -3.0
15 ≤ 20 years 115 (86.5) 2.7 1.6 -4.8 53 (39.8) 2.0 1.2 -3.0
≥ 20 years 293 (88.5) 3.1 2.1 -4.8 155 (46.8) 1.9 1.3 -2.7
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Table V – Concordant and discordant tuberculin skin test (TST) >10 mm and interferon -γ -release assay (IGRA) results depending on putative risk factors
TST/IGRA
neg/neg pos/neg neg/pos pos/pos
Age N % N % N % N %
<0.001
16 -29 years 162 27.0 306 50.9 14 2.3 119 19.8
30 -39 years 98 21.2 215 46.4 9 1.9 141 30.5
40 -49 years 39 12.5 147 47.0 3 1.0 124 39.6
50 -59 years 28 10.3 114 42.1 5 1.8 124 45.8
≥ 60 years 5 14.7 10 29.4 2 5.9 17 50.0
Gender
Female 236 19.5 585 48.3 24 2.0 366 30.2
0.41
Male 96 20.4 207 43.9 9 1.9 159 33.8
BCG vaccination
Only at birth 75 15.1 189 38.0 6 1.2 228 45.8
<0.001
Plus one additional 129 20.4 303 48.0 15 2.4 184 29.2
Plus two 89 22.5 209 52.8 11 2.8 87 22.0
Plus 3 -10 39 24.8 91 58.0 1 0.6 26 16.6
Years since last BCG
> 15 years 225 18.0 543 43.5 26 2.1 453 36.3
<0.001>10 -15 years 84 30.3 140 50.5 5 1.8 48 17.3
1 -10 years 23 14.6 109 69.0 2 1.3 24 15.2
Profession
Administrative 33 13.1 114 45.4 6 2.4 98 39.0
<0.001
Auxiliaries, cleaning 52 20.5 103 40.6 5 2.0 94 37.0
Technicians 23 19.3 62 52.1 2 1.7 32 26.9
Nurses 151 21.0 387 53.8 10 1.4 172 23.9
Physicians 73 21.6 126 37.3 10 3.0 129 38.2
Risk assessment
Low risk 25 11.2 100 44.8 6 2.7 92 41.3
0.001Moderate risk 120 19.2 302 48.2 9 1.4 195 31.2
High risk 187 22.4 390 46.8 18 2.2 238 28.6
Years in healthcare
Start of work 94 26.9 162 46.4 12 3.4 81 23.2
<0.001
< 5 years 103 26.0 196 49.5 4 1.0 93 23.5
5 ≤ 10 years 56 21.3 123 46.8 9 3.4 75 28.5
10 ≤ 15 years 29 13.8 105 50.0 2 1.0 74 35.2
15 ≤ 20 years 18 13.5 62 46.6 0 0 53 39.8
≥ 20 years 32 9.7 144 43.5 6 1.8 149 45.0
Total 332 19.7 792 47.1 33 2.0 525 31.2
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increased the proportion of TST -/QFT+ re-
sults in the whole population from 2% to 
12%. TST was more than twice as often 
positive than the QFT. Therefore, TST+/
QFT– results were more often observed 
than concordant negative or positive results. 
In none of the HCWs with a TST+/QFT– 
result active TB was diagnosed during the 
study period.
So far little is known about the effect of re-
peated BCG vaccination on the probability 
of TST+/IGRA– discordant results20,21. Ac-
cording to the Portuguese National Vaccina-
tion Plan, BCG vaccination is administered 
in newborns18. Therefore, the effect of BCG 
vaccination on TST and QFT could not be 
studied. Nevertheless it could be shown that 
repeated BCG vaccination increased the 
probability of TST+/QFT– results. When 
re -vaccination was performed during the last 
10 years the chance for discordant TST+/
QFT– results was highest (69%) while at the 
same time probability of concordant posi-
tive results was low (15.2%).
Contrary to our preliminary analysis with a 
smaller sample not only QFT but also TST 
showed that years working in healthcare are 
a risk factor for LTBI22. Surprisingly, neither 
risk assessment nor profession was associat-
ed with TST or IGRA. In the two European 
fingerprint studies, the majority of work-
related active TB cases occurred when the 
infection risk was not suspected and preven-
tive measures were not taken23, 24. Rotation 
of the staff is another explanation for the 
lack of this association, as well as the cross-
sectional design of our study, which might 
dilute the expected association.
The high proportion of TST positive HCWs 
with repeated BCG vaccination corrobo-
rates the conclusion of other authors that 
TST is not very helpful in populations in 
which most people are vaccinated and in 
which vaccination is repeated25. In those 
populations the QFT is a promising alter-
native even though it is still not clear how 
the QFT will perform in serial testing. 
While unlike with the TST26, the test results 
cannot be influence by previous QFT, the 
definition for conversions and reversions of 
the QFT are not yet well established. Fur-
ther research will have to elucidate the ques-
tion about how changes in interferon -γ con-
centration over time indicate real new 
infections or clearance of the Mycobacteria 
can be distinguished from changes in con-
centration due to natural variation27,28.
Additionally, and despite our increasing 
knowledge, several key questions about la-
tent infection and reactivation of M. tuber-
culosis remain unanswered. Particularly, it 
should be noted that both the TST and the 
IGRA are designed to identify an adaptive 
immune response against M. tuberculosis, 
but not necessarily a latent infection. A po-
sitive result of currently available diagnostic 
tests is primarily a measure of an immuno-
logical response to stimulation by mycobac-
terial antigens that should not, therefore, be 
equated with the presence of live M. tuber-
culosis in the human host. The proportion 
of individuals who truly remain infected 
with M. tuberculosis after TST or IGRA 
conversion is unknown. It is also uncertain 
how long adaptive immune responses to-
wards mycobacterial antigens persist in the 
absence of live mycobacteria. For these rea-
sons, according to the recently published 
TBNET consensus statement regarding la-
tent TB, based on the informative value 
presently derived by IGRA and TST, the 
term “latent infection” would at best impli-
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cate “lasting tuberculosis immune respon-
ses” and not necessarily identify a true latent 
infection with viable microorganisms and 
potential risk of developing active di-
sease29,30. Further studies are needed. Portu-
guese LTBI treatment guidelines31, which 
were revised in 2006, need to be updated, in 
order to address this question. Whether 
treatment can be monitored by follow -up of 
the interferon -γ release is another interest-
ing question to be studied in future32.
Considering the limitations that both tests 
present, the best solution seems to be the 
use of both, using the IGRA higher specifi-
city for confirming a positive TST. This op-
tion allows us to take advantage of the best 
characteristics of each test30.
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